BioCentury
ARTICLE | Clinical News

Deprenyl Animal Health Inc. regulatory update

February 27, 1995 8:00 AM UTC

DAHI received notice of allowance on a European patent covering the use of Anipryl (selegiline hydrochloride) to treat canine Cushing's disease, an endocrine disorder. The Overland Park, Kan., company...